Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3154 | Pulmozyme Wiki | 0.50 |
| drug2916 | Placebo Wiki | 0.03 |
Navigate: Correlations HPO
There are 2 clinical trials
Moderate to severe cases of SARS-associated ARDS based on inclusion/ exclusion criteria and the decision made in multi- disciplinary team are treated with 0.5 Gy whole lung radiation.
Description: O2 saturation
Measure: Change from baseline blood oxygenation Time: 28 daysDescription: Total days the patient is admitted to hospital
Measure: Number of Hospital stay days Time: 28 daysDescription: Total days the patient is admitted to ICU
Measure: Number of ICU stay days Time: 28 daysDescription: Total number of intubations performed after the treatment
Measure: Number of intubation events Time: 28 daysDescription: Changes in WBC count if base-line is abnormal
Measure: WBC Time: 28 daysDescription: Changes in Platelets count if base-line is abnormal
Measure: Platelets Time: 28 daysDescription: Changes in CRP serum level
Measure: CRP Time: Day 1Description: Changes in CRP serum level
Measure: CRP Time: Day 2Description: Changes in CRP serum level
Measure: CRP Time: Day 3Description: Changes in CRP serum level
Measure: CRP Time: Day 4Description: Changes in CRP serum level
Measure: CRP Time: Day 5Description: Changes in IL-6 serum level
Measure: IL-6 Time: Day 1Description: Changes in IL-6 serum level
Measure: IL-6 Time: Day 2Description: Changes in IL-6 serum level
Measure: IL-6 Time: Day 3Description: Changes in IL-6 serum level
Measure: IL-6 Time: Day 4Description: Changes in IL-6 serum level
Measure: IL-6 Time: Day 5There are several clinical studies that mention the benefits of treatment with low-dose radiation therapy to patients with COVID 19, so this study protocol will be started to determine if there is clinical improvement with treatment and low-dose radiation therapy. to all the lung.
Description: improvement of oxygen saturation
Measure: Clinical improvement Time: 7 daysDescription: improvement in acute phase reactants and simple tomography
Measure: improvement of laboratory and imaging parameters Time: 7 -14 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports